NCT05333419 - Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

June 12, 2023

Study Completion Date

September 30, 2023

Conditions

Open Angle GlaucomaOcular Hypertension

Interventions

DRUG

100ng/day PA5346 Latanoprost FA SR Ocular Implant

PA5346 ocular implant is a small, clear rod-shaped implant that is placed in the anterior (front) chamber of the eye, at a single timepoint, and slowly releases a drug called latanoprost free acid (100ng/day) over a period of approximately 30 weeks

Trial Locations (2)

3015

Rotorua Eye Clinic, Rotorua

6011

Capital Eye Specialists, Te Aro